Y K Kim1, G Park, C S Kim, H C Yu, Y M Han. 1. Department of Diagnostic Radiology and Research Institute of Clinical Medicine, Chonbuk National University Hospital and Medical School, Seoul, Republic of Korea. jmyr@dreamwiz.com
Abstract
OBJECTIVES: We compared the diagnostic performance of gadoxetic acid-enhanced MRI and 16-slice multidetector CT (MDCT) with respect to their abilities to detect hepatic metastases and differentiate hepatic metastases from hepatic cysts and haemangiomas. METHODS: 67 patients with 110 liver metastases (size 0.3-2.5 cm), 33 haemangiomas (size 0.5-1.5 cm) and 17 cysts (size 0.3-1.0 cm) underwent 4-phase MDCT and gadoxetic acid-enhanced MRI, including early dynamic phases, post-contrast T(2) weighted turbo spin echo sequences and 20 min hepatocyte-selective phases. Two observers independently analysed each image in random order. Sensitivity and diagnostic accuracy for lesion detection and differentiation for MDCT and gadoxetic acid-enhanced MRI were calculated using receiver operating characteristic analysis. RESULTS: For both observers, the Az values of gadoxetic acid-enhanced MRI (mean, 0.982 and 0.981) were significantly higher than the Az values of MDCT (mean, 0.839 and 0.892) (p<0.05) for the detection of metastases and for the differentiation of metastases from haemangiomas and cysts. Sensitivities of gadoxetic acid-enhanced MRI with regard to the detection and characterisation of liver metastases (mean, 96.9% and 96.0%) were significantly higher than those of MDCT (mean, 78.7% and 75.0%) (p<0.05). CONCLUSION: Gadoxetic acid-enhanced MRI showed higher diagnostic accuracy and sensitivity than did MDCT for the detection of hepatic metastases and for the differentiation between hepatic metastases and hepatic haemangiomas or cysts.
OBJECTIVES: We compared the diagnostic performance of gadoxetic acid-enhanced MRI and 16-slice multidetector CT (MDCT) with respect to their abilities to detect hepatic metastases and differentiate hepatic metastases from hepatic cysts and haemangiomas. METHODS: 67 patients with 110 liver metastases (size 0.3-2.5 cm), 33 haemangiomas (size 0.5-1.5 cm) and 17 cysts (size 0.3-1.0 cm) underwent 4-phase MDCT and gadoxetic acid-enhanced MRI, including early dynamic phases, post-contrast T(2) weighted turbo spin echo sequences and 20 min hepatocyte-selective phases. Two observers independently analysed each image in random order. Sensitivity and diagnostic accuracy for lesion detection and differentiation for MDCT and gadoxetic acid-enhanced MRI were calculated using receiver operating characteristic analysis. RESULTS: For both observers, the Az values of gadoxetic acid-enhanced MRI (mean, 0.982 and 0.981) were significantly higher than the Az values of MDCT (mean, 0.839 and 0.892) (p<0.05) for the detection of metastases and for the differentiation of metastases from haemangiomas and cysts. Sensitivities of gadoxetic acid-enhanced MRI with regard to the detection and characterisation of liver metastases (mean, 96.9% and 96.0%) were significantly higher than those of MDCT (mean, 78.7% and 75.0%) (p<0.05). CONCLUSION:Gadoxetic acid-enhanced MRI showed higher diagnostic accuracy and sensitivity than did MDCT for the detection of hepatic metastases and for the differentiation between hepatic metastases and hepatic haemangiomas or cysts.
Authors: Juha Halavaara; Josy Breuer; Carmen Ayuso; Thomas Balzer; Marie-France Bellin; Lennart Blomqvist; Rick Carter; Luigi Grazioli; Renate Hammerstingl; Alexander Huppertz; Gregor Jung; Denis Krause; Andrea Laghi; Edward Leen; Luciano Lupatelli; Luca Marsili; Julio Martin; E Scott Pretorius; Caroline Reinhold; Michael Stiskal; Alan H Stolpen Journal: J Comput Assist Tomogr Date: 2006 May-Jun Impact factor: 1.826
Authors: Carlo Bartolozzi; Francescamaria Donati; Dania Cioni; Carlo Procacci; Giovanni Morana; Antonio Chiesa; Luigi Grazioli; Giorgio Cittadini; Giuseppe Cittadini; Andrea Giovagnoni; Giovanni Gandini; Jochen Maass; Riccardo Lencioni Journal: Eur Radiol Date: 2003-08-09 Impact factor: 5.315
Authors: Tito Livraghi; Luigi Solbiati; Franca Meloni; Tiziana Ierace; S Nahum Goldberg; G Scott Gazelle Journal: Cancer Date: 2003-06-15 Impact factor: 6.860
Authors: Masoom A Haider; Marianne M Amitai; Daniel C Rappaport; Martin E O'Malley; Anthony E Hanbidge; Mark Redston; Gina A Lockwood; Steven Gallinger Journal: Radiology Date: 2002-10 Impact factor: 11.105
Authors: Alexander Huppertz; Thomas Balzer; Anthony Blakeborough; Josy Breuer; Andrea Giovagnoni; Gertraud Heinz-Peer; Michael Laniado; Riccardo M Manfredi; Didier G Mathieu; Dieter Mueller; Peter Reimer; Philip J Robinson; Michael Strotzer; Matthias Taupitz; Thomas J Vogl Journal: Radiology Date: 2004-01 Impact factor: 11.105
Authors: Thomas D Vreugdenburg; Ning Ma; Joanna K Duncan; Dagmara Riitano; Alun L Cameron; Guy J Maddern Journal: Int J Colorectal Dis Date: 2016-09-29 Impact factor: 2.571
Authors: Michael Haimerl; Max Wächtler; Ivan Platzek; Rene Müller-Wille; Christoph Niessen; Patrick Hoffstetter; Andreas Georg Schreyer; Christian Stroszczynski; Philipp Wiggermann Journal: BMC Med Imaging Date: 2013-12-01 Impact factor: 1.930